Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| 1 |
Apple
AAPL
|
+$652M |
| 2 |
SPDR S&P 500 ETF Trust
SPY
|
+$518M |
| 3 |
iShares MBS ETF
MBB
|
+$406M |
| 4 |
Procter & Gamble
PG
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$351M |
Top Sells
| 1 |
Invesco QQQ Trust
QQQ
|
+$642M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$570M |
| 3 |
Sempra
SRE
|
+$490M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| 1 | Technology | 17.54% |
| 2 | Healthcare | 11.42% |
| 3 | Financials | 10.41% |
| 4 | Consumer Discretionary | 9.33% |
| 5 | Communication Services | 9.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
951
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.4B
| $8.01M | ﹤0.01% |
149,407
+148,975
| +34,485% | +$7.99M |
|
952
PTC Therapeutics
PTCT
$4.8B
| $8.01M | ﹤0.01% |
166,806
-121,499
| -42% | -$5.83M |
|
953
Churchill Downs
CHDN
$6.68B
| $7.95M | ﹤0.01% |
115,890
+63,148
| +120% | +$4.33M |
|
954
TransUnion
TRU
$17.5B
| $7.94M | ﹤0.01% |
92,720
-123,096
| -57% | -$10.5M |
|
955
Kinross Gold
KGC
$28.6B
| $7.91M | ﹤0.01% |
1,669,285
+1,070,074
| +179% | +$5.07M |
|
956
Vale
VALE
$46.4B
| $7.84M | ﹤0.01% |
593,633
-2,948,029
| -83% | -$38.9M |
|
|
SAGE
957
DELISTED
Sage Therapeutics
SAGE
| $7.83M | ﹤0.01% |
108,419
+72,410
| +201% | +$5.23M |
|
958
ManpowerGroup
MAN
$1.73B
| $7.78M | ﹤0.01% |
80,093
-32,518
| -29% | -$3.16M |
|
959
Liberty Media Series C
FWONK
$25.9B
| $7.77M | ﹤0.01% |
174,887
+9,635
| +6% | +$428K |
|
|
SAVE
960
DELISTED
Spirit Airlines, Inc.
SAVE
| $7.77M | ﹤0.01% |
192,637
+88,924
| +86% | +$3.58M |
|
961
BP
BP
$87.8B
| $7.68M | ﹤0.01% |
203,394
-200,869
| -50% | -$7.58M |
|
|
NBR.PRA
962
DELISTED
Nabors Industries Ltd. 6.00% Mandatory Convertible Preferred Shares, Series A
NBR.PRA
| $7.67M | ﹤0.01% |
339,651
-71,000
| -17% | -$1.6M |
|
|
MYOK
963
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $7.65M | ﹤0.01% |
105,020
+75,750
| +259% | +$5.52M |
|
964
Regenxbio
RGNX
$449M
| $7.65M | ﹤0.01% |
186,668
+125,679
| +206% | +$5.15M |
|
965
Ciena
CIEN
$19.6B
| $7.64M | ﹤0.01% |
178,928
+64,645
| +57% | +$2.76M |
|
966
Neurocrine Biosciences
NBIX
$14.4B
| $7.63M | ﹤0.01% |
71,004
+18,501
| +35% | +$1.99M |
|
967
EPAM Systems
EPAM
$8.7B
| $7.63M | ﹤0.01% |
35,977
-5,911
| -14% | -$1.25M |
|
|
RARX
968
DELISTED
Ra Pharmaceuticals, Inc. Common Stock
RARX
| $7.62M | ﹤0.01% |
162,443
+143,217
| +745% | +$6.72M |
|
969
CubeSmart
CUBE
$9.17B
| $7.6M | ﹤0.01% |
241,558
-132,341
| -35% | -$4.17M |
|
970
Reinsurance Group of America
RGA
$12.3B
| $7.59M | ﹤0.01% |
46,567
-76,069
| -62% | -$12.4M |
|
971
DexCom
DXCM
$26.5B
| $7.59M | ﹤0.01% |
138,740
-16,244
| -10% | -$888K |
|
|
ENLC
972
DELISTED
ENLINK MIDSTREAM, LLC
ENLC
| $7.56M | ﹤0.01% |
1,232,766
+160,981
| +15% | +$987K |
|
973
Emcor
EME
$28.3B
| $7.56M | ﹤0.01% |
87,544
+15,076
| +21% | +$1.3M |
|
|
CONE
974
DELISTED
CyrusOne Inc Common Stock
CONE
| $7.56M | ﹤0.01% |
115,479
-17,087
| -13% | -$1.12M |
|
975
NovaGold Resources
NG
$3.06B
| $7.54M | ﹤0.01% |
841,082
+592,056
| +238% | +$5.3M |
|